Multiplex Assay Kit for Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay)

Protectin; MIC11; MIN1; MIN2; MIN3; MSK21; MAC-IP; MACIF; MIRL; HRF20; Complement Regulatory Protein; 20 kDa homologous restriction factor; Membrane attack complex inhibition factor

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-104 101
EDTA plasma(n=5) 97-105 101
heparin plasma(n=5) 94-101 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-99% 91-105% 96-105% 80-92%
EDTA plasma(n=5) 82-96% 80-104% 85-103% 81-97%
heparin plasma(n=5) 80-94% 95-103% 85-103% 80-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CD59) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Sci Rep Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation Pubmed:27215188
J Periodontal Res Salivary levels of last generation specific pro©\resolving lipid mediators (SPMs)(protectin and maresin) in patients with cardiovascular and periodontal disease: A case ¡­ 33650687
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB336Hu61 Active Cluster of Differentiation 59 (CD59) Cell culture; Activity Assays.
APB336Hu62 Active Cluster of Differentiation 59 (CD59) Cell culture; Activity Assays.
EPB336Hu61 Eukaryotic Cluster of Differentiation 59 (CD59) Positive Control; Immunogen; SDS-PAGE; WB.
RPB336Hu01 Recombinant Cluster of Differentiation 59 (CD59) Positive Control; Immunogen; SDS-PAGE; WB.
EPB336Hu62 Eukaryotic Cluster of Differentiation 59 (CD59) Positive Control; Immunogen; SDS-PAGE; WB.
PAB336Hu01 Polyclonal Antibody to Cluster of Differentiation 59 (CD59) WB; IHC; ICC; IP.
FAB336Hu01 Anti-Cluster of Differentiation 59 (CD59) Polyclonal Antibody Flow cytometry.
LAB336Hu71 Biotin-Linked Polyclonal Antibody to Cluster of Differentiation 59 (CD59) WB; IHC; ICC.
MAB336Hu22 Monoclonal Antibody to Cluster of Differentiation 59 (CD59) WB; IHC; ICC; IP.
MAB336Hu26 Monoclonal Antibody to Cluster of Differentiation 59 (CD59) WB; IHC; ICC; IP.
FAB336Hu02 Anti-Cluster of Differentiation 59 (CD59) Monoclonal Antibody FCM
SEB336Hu ELISA Kit for Cluster of Differentiation 59 (CD59) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB336Hu Multiplex Assay Kit for Cluster of Differentiation 59 (CD59) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.